Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q1 2026 Earnings Call Transcript May 12, 2026
Capricor Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.59 EPS, expectations were $-0.55.
Operator: Good afternoon, ladies and gentlemen, and welcome to the Capricor Therapeutics First Quarter 26 Conference Call. At this time, all participant lines are in listen only mode. Following the presentation, we will conduct a question and answer session. If at any time during this call...
